Naloxone Reversed Morphine and THC Movement Suppression Differently in Rats

In a 1982 rat study, naloxone completely reversed acute morphine-related movement suppression but only partly reversed THC-related suppression. Similar behavior did not mean identical pharmacological control.

Acute and repeated conditions were compared

High doses of either morphine or THC initially reduced locomotor activity. By the third treatment day, tolerance to that inhibitory effect developed. Partial cross-tolerance to THC-related suppression was also observed. These findings concern movement under the specified dosing conditions, not every action of either drug.

The antagonist response depended on exposure history

Naloxone had different effects in the tolerant groups: a slight activity reduction in THC-tolerant rats and increased activity in morphine-tolerant rats. The change cannot be summarized as a uniform stimulation or reversal of sedation independent of the preceding drug.

Partial reversal does not prove a shared primary receptor

The study is consistent with interaction between systems, but a behavioral antagonist comparison does not establish that THC and morphine act through the same receptor. Indirect pathways can affect a shared outcome, and the supplied abstract does not isolate a complete mechanism.

This historical experiment contributes a direct comparison of drug history and antagonist response. It does not establish naloxone as a clinical antidote to cannabis effects or supply guidance for intoxicated patients. Species, dose-related movement suppression and partial versus complete reversal are central to its interpretation.

Related: interpreting cannabis tolerance claims.

Research cited

Tulunay FC; Ayhan IH; Sparber SB. The effects of morphine and delta-9-tetrahydrocannabinol on motor activity in rats. Psychopharmacology (1982). doi:10.1007/BF00433741. Findings discussed from the study abstract.